Compared to Estimates, Morgan Stanley (MS) Q4 Earnings: A Look at Key Metrics

15.01.26 15:30 Uhr

Werte in diesem Artikel
Aktien

165,08 EUR 0,54 EUR 0,33%

Indizes

PKT PKT

18.746,4 PKT 13,8 PKT 0,07%

3.437,3 PKT -0,8 PKT -0,02%

6.944,6 PKT 0,1 PKT 0,00%

For the quarter ended December 2025, Morgan Stanley (MS) reported revenue of $17.89 billion, up 10.3% over the same period last year. EPS came in at $2.68, compared to $2.22 in the year-ago quarter.The reported revenue represents a surprise of +3.3% over the Zacks Consensus Estimate of $17.32 billion. With the consensus EPS estimate being $2.41, the company has not delivered EPS surprise.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Morgan Stanley performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Book value per common share: $64.37 versus $63.87 estimated by four analysts on average.Return on average common equity: 16.9% versus 14.6% estimated by four analysts on average.Wealth Management - Total client assets: $7,381.00 billion versus the two-analyst average estimate of $6,832.69 billion.Total assets under management: $1,895.00 billion versus $1,823.49 billion estimated by two analysts on average.Net interest Revenue: $2.86 billion compared to the $2.53 billion average estimate based on four analysts. The reported number represents a change of +11.9% year over year.Total non-interest revenues: $15.04 billion compared to the $14.49 billion average estimate based on three analysts. The reported number represents a change of +10% year over year.Revenues- Wealth Management- Transactional: $1.14 billion compared to the $1.19 billion average estimate based on three analysts. The reported number represents a change of +17.5% year over year.Revenues- Wealth Management- Net interest income: $2.11 billion versus $1.99 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +11.8% change.Revenues- Wealth Management- Other: $147 million versus the three-analyst average estimate of $141.89 million. The reported number represents a year-over-year change of -27.6%.Revenues- Investment Management - Asset management and related fees: $1.65 billion versus the three-analyst average estimate of $1.56 billion. The reported number represents a year-over-year change of +6.1%.Revenues- Investment Management- Performance-based income and other: $71 million versus $115.88 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -19.3% change.Revenues- Wealth Management- Asset management: $5.03 billion compared to the $4.81 billion average estimate based on three analysts. The reported number represents a change of +13.9% year over year.View all Key Company Metrics for Morgan Stanley here>>>Shares of Morgan Stanley have returned +3.4% over the past month versus the Zacks S&P 500 composite's +1.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Morgan Stanley (MS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Morgan Stanley und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf CGI Group

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CGI Group

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Morgan Stanley

Wer­bung

Analysen zu Morgan Stanley

DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
20.04.2021Morgan Stanley kaufenCredit Suisse Group
DatumRatingAnalyst
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
20.04.2021Morgan Stanley kaufenCredit Suisse Group
15.10.2020Morgan Stanley OutperformRBC Capital Markets
05.10.2020Morgan Stanley OutperformRBC Capital Markets
DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
02.04.2020Morgan Stanley neutralDeutsche Bank AG
21.01.2020Morgan Stanley NeutralCitigroup Corp.
04.04.2019Morgan Stanley HoldHSBC
DatumRatingAnalyst
20.01.2016Morgan Stanley SellSociété Générale Group S.A. (SG)
25.07.2011Morgan Stanley underperformRBC Capital Markets
02.10.2009Morgan Stanley underperformCalyon Securities Inc.
31.08.2005Morgan Stanley underweightPrudential Financial
28.07.2005Morgan Stanley underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Morgan Stanley nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen